1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Taran Therapeutics Acquires Humanigen

M&A Deal Summary

Taran Therapeutics Acquires Humanigen

On September 25, 2024, Taran Therapeutics acquired life science company Humanigen for 2M USD

Acquisition Highlights
  • This is Taran Therapeutics’ 1st transaction in the Life Science sector.
  • This is Taran Therapeutics’ largest (disclosed) transaction.
  • This is Taran Therapeutics’ 1st transaction in the United States.
  • This is Taran Therapeutics’ 1st transaction in California.

M&A Deal Summary
Date 2024-09-25
Target Humanigen
Sector Life Science
Buyer(s) Taran Therapeutics
Deal Type Add-on Acquisition
Deal Value 2M USD
Advisor(s) SC&H (Financial)

Target

Humanigen

Short Hills, California, United States
Humanigen is a bio-pharmaceutical company. Humanigen was founded in 2000 and is based in Short Hills, New Jersey.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Taran Therapeutics

San Francisco, California, United States
Category Company
Sector Life Science
DESCRIPTION

Taran Therapeutics is a privately-owned biotech pioneering late-stage therapy for hematology/oncology and chronic inflammation. Taran Therapeutics is based in San Francisco, California.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1
Size (of disclosed) 1 of 1
Mergr

Solution for

Product

Company

Legal